Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Park (Seoul, Republic of Korea), O. Kim (Seoul, Republic of Korea), B. Kwon (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea). Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease. 2160

Member's Comments

No comment yet.

Related content which might interest you: Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 The value of semi-quantitative mycobacterial cultures for predicting culture conversion during MAC lung disease therapy Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Short term outcome of patients with advanced bronchiectasis and healed pulmonary tuberculosis from ICU Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Predicted versus observed respiratory parameters after lung resection in different postoperative periods in pulmonary tuberculosis patients Source: International Congress 2019 – General thoracic surgery Year: 2019 Factors associated with sputum culture conversion in patients with pulmonary tuberculosis Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Predictors of delayed sputum culture conversion in tuberculosis patients Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Analysis of clinical course after pulmonary resection for mycobacterium avium complex lung disease in our hospital Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions Year: 2014 Therapeutic outcomes for cavitary Mycobacterium avium complex (MAC) lung disease Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Investigation burden in patients with fibrotic interstitial lung disease in their terminal admission Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Mortality causes in patients with advanced lung disease in long term oxygen therapy Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007 Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003 Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013